Fibronectin Secures Approval from Indian Food & Drug Administration

Earlier, treating chronic wounds (wounds that are not healing from more than 4 weeks) was a challenge. The success rate, even today, is less than 50% with a relapsing rate of more than 70%. We, at PRG Pharma Pvt Ltd, would like to officially announce that we have developed the world\'s first commercial Fibronectin (FN) that will aid advanced wound management in India. Fibronectin or FN is the b